Cipta Sarana Medika Tbk. vs Tunas Baru Lampung Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Tunas Baru Lampung Tbk. trades at Rp635 (market cap 3.83T, 534.8K 24h volume). The key difference: Tunas Baru Lampung Tbk. is far larger — about 24.2× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 534.8K). Which is the better fit depends on your goals.
| DKHH | TBLA | |
|---|---|---|
Market Cap | 158.12B | 3.83T |
Volume | 8.21M | 534.8K |
Lot | 82.15K | 5.35K |
Turnover | 515.2M | 338.53M |
Average Price | 62.72 | 633 |
Value | 515.2M | 338.53M |
Indicative Equilibrium Price | 63 | 635 |
Indicative Equilibrium Volume | 1.33K | 220 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Tunas Baru Lampung Tbk (the Company) was established by virtue of Notarial Deed No. 23 dated December 22, 1973 of Halim Kurniawan, S.H., public notary in Teluk Betung. PT. Tunas Baru Lampung is a member of Sungai Budi Group which was founded in 1947 and is a pioneer in Indonesia`s agricultural industry.
Read more on TBLA →